Table 13.
Summary of energy transfer devices: in vivo examples.
Yea | Organism | Location | Material | Frequency or wavelength |
Distance between source and receiver |
Critical feature size of implant |
Power | Power density | Efficiency | Operation regime |
Application | Duration | References |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
APT | |||||||||||||
2001 | Goat | Subcutaneous space | PZT | 1 MHz | 15 mm | 30 mm (diameter), 5 mm (height) | 34 mW | – | – | – | Implants | – | [445] |
2013 | Human | Heart | WiCS-LV system (commercial) | – | ≈10 cm | – | Successfully derived cardiac pacing devices | – | – | – | Cardiac pacing | – | [444] |
2016 | Pig | Subcutaneous space | PZT (commercial) | 1 MHz | 10–15 mm | 70 mm (diameter) | 300 mW | – | – | – | Implants | 5 weeks | [440] |
2016 | Rat | Peripheral nervous system and skeletal muscle | PZT | 1.85 MHz | 8.8 mm | 0.8 × 3 × 1 mm3 | 40 μW | – | – | – | Peripheral nerve neuro recording | – | [442] |
WPT | |||||||||||||
2015 | Rat | Near stomach | – | 1 MHz | 5–10 mm | 20 mm (diameter) | 127 mW | 40.4 mW cm−2 | – | Near-field | Peripheral nerve prostheses | – | [470] |
2009 | Pig | Lower abdomen | – | 7 MHz | 10 cm | 41 mm | Lighting an LED | – | – | Near-field | Brain and subcutaneous implants | – | [465] |
2015 | Pig | Skull | – | 907.5 MHz | 27 mm | 1 mm3 | 26.8 mW | 26.8 W cm−3 | – | Near-field | Brain-machine interface | – | [466] |
2014 | Pig | Chest and brain | – | 1.6 GHz | 5 cm | 2 mm (diameter), 3.5 mm (height) | 2.2, 1.7 mW (brain, heart) | 200, 155 mW cm3 (brain, heart) | – | Mid-field | Cardiac pacing | – | [91] |
2014 | Rabbit | Heart | – | 1.6GHz | 5 cm | 2 mm (diameter), 3.5 mm (height) | Powering a cardiac pacer | – | – | Mid-field | Cardiac pacing | – | [91] |
2017 | Pig | GI tract | – | 1.2 GHz | – | 6.8 × 6.8 mm2 | 37.5, 123, and 173 μW (esophagus, stomach, colon) | 81, 266, and 374 μW cm−2 (esophagus, stomach, colon) | – | Mid-field | Ingestible electronics | – | [459] |
2011 | Rabbit | Eye | – | 3 GHz | 5 cm | 8 × 4 × 2 mm3 | 300 mW | 4.69 W cm−3 | – | Far-fie Id | IOP monitoring | – | [106] |
Optical power transfer | |||||||||||||
2012 | Rats | Eye (subretinal region) | Silicon | 880 nm | – | 0.8 mm × 1.2 mm | 480 μW | 50 mW cm−2 | – | NIR | Retinal prosthesis | 90 days | [492] |
2013 | Rats | Eye (subretinal region) | Silicon | 915 nm | – | 0.8 mm × 1.2 mm | 240 μW–2 mW | 25–210 mW cm−2 | – | NIR | Retinal prosthesis | 6 months | [493] |
2015 | Rats | Eye (subretinal region) | Silicon | 880–915 nm | – | 1 mm × 1 mm | 550 μW | 55 mW cm−2 | – | NIR | Retinal prosthesis | – | [474] |
2016 | Rats | Subcutaneous space (back) | GaInP/GaAs | Standard solar spectrum (AM1.5g) | 539–675 μm | 760 μm × 760 μm × 14 | 647 μW | 10 mW cm−2 | 6.9–9.5% | Sunlight | Pacemaker | 4 weeks | [489] |
2017 | Rats | Subdermal, bone, muscle, organs, thorax | Silicon | 850 nm | 15–4 mm | 1.23 mm2 | 0.21–9.53 μW | 17–77.5 μW cm−2 | 0.12–5.79% | NIR (low intensity) | Mm scale depth implants | – | [476] |
2017 | Rats | Subdermal, bone, muscle, organs, thorax | GaAs | 850 nm | 15–4 mm | 1.23 mm2 | 0.36–15.1 μW | 29–1224 μW cm−2 | 0.21–9.13% | NIR (low intensity) | Mm scale depth implants | – | [476] |
2018 | Rats | Infrascapular region | Silicon | 780 nm | 2 mm | 390 μm × 410 μm × 72 | 64.4 μW | 560 μW cm−2 | 0.28% | NIR (low intensity) | Biodegradable implants | 4 months | [491] |